MedTrace Logo

Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects

NCT01470261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1398

Last updated 2016-09-21

No results posted yet for this study

Summary

The aim of the ADDUCE project is to investigate any adverse effects of methylphenidate (trade name ritalin) on growth, neurological system, psychiatric states and cardiovascular system over a two year period in children and adults.

Conditions

  • Attention Deficit Hyperactivity Disorder (ADHD)

Sponsors & Collaborators

  • Zentralinstitut für Seelische Gesundheit Mannheim

    collaborator OTHER

  • Universita degli Studi di Cagliari

    collaborator UNKNOWN

  • Vadaskert Child and Adolescent Psychiatric Hospital

    collaborator OTHER

  • NHS Tayside

    lead OTHER_GOV

Principal Investigators

  • David Coghill, ' · University of Dundee

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2016-01-31
Completion
2016-04-30

Countries

  • Germany
  • Hungary
  • Italy
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01470261 on ClinicalTrials.gov